Skip to main content
NCBI home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2002 Dec;56(12):899–902. doi: 10.1136/jech.56.12.899

Cancer screening

A Barratt 1, P Mannes 1, L Irwig 1, L Trevena 1, J Craig 1, L Rychetnik 1
PMCID: PMC1756972  PMID: 12461108

Full Text

The Full Text of this article is available as a PDF (80.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson I., Aspegren K., Janzon L., Landberg T., Lindholm K., Linell F., Ljungberg O., Ranstam J., Sigfússon B. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988 Oct 15;297(6654):943–948. doi: 10.1136/bmj.297.6654.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baines C. J., To T., Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer. 1990 Apr 1;65(7):1663–1669. doi: 10.1002/1097-0142(19900401)65:7<1663::aid-cncr2820650735>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  3. Barratt A., Irwig L., Glasziou P., Cumming R. G., Raffle A., Hicks N., Gray J. A., Guyatt G. H. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA. 1999 Jun 2;281(21):2029–2034. doi: 10.1001/jama.281.21.2029. [DOI] [PubMed] [Google Scholar]
  4. Eddy D. M. Comparing benefits and harms: the balance sheet. JAMA. 1990 May 9;263(18):2493–passim. doi: 10.1001/jama.263.18.2493. [DOI] [PubMed] [Google Scholar]
  5. Fletcher S. W. Evidence-based screening: what kind of evidence is needed? ACP J Club. 1998 May-Jun;128(3):A12–A14. [PubMed] [Google Scholar]
  6. Glasziou P. P. Meta-analysis adjusting for compliance: the example of screening for breast cancer. J Clin Epidemiol. 1992 Nov;45(11):1251–1256. doi: 10.1016/0895-4356(92)90166-k. [DOI] [PubMed] [Google Scholar]
  7. Goyder E., Barratt A., Irwig L. M. Telling people about screening programmes and screening test results: how can we do it better? J Med Screen. 2000;7(3):123–126. doi: 10.1136/jms.7.3.123. [DOI] [PubMed] [Google Scholar]
  8. Law M. R. The number needed to screen--an adaptation of the number needed to treat. J Med Screen. 2001;8(3):114–115. doi: 10.1136/jms.8.3.114. [DOI] [PubMed] [Google Scholar]
  9. Nottingham J. Women must be given fully informed information about cervical screening. BMJ. 1999 Jun 5;318(7197):1555–1556. doi: 10.1136/bmj.318.7197.1555a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Olsen O., Gøtzsche P. C. Cochrane review on screening for breast cancer with mammography. Lancet. 2001 Oct 20;358(9290):1340–1342. doi: 10.1016/S0140-6736(01)06449-2. [DOI] [PubMed] [Google Scholar]
  11. Petticrew M. P., Sowden A. J., Lister-Sharp D., Wright K. False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess. 2000;4(5):1–120. [PubMed] [Google Scholar]
  12. Quinn M., Babb P., Jones J., Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999 Apr 3;318(7188):904–908. doi: 10.1136/bmj.318.7188.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Raffle A. E. Information about screening - is it to achieve high uptake or to ensure informed choice? Health Expect. 2001 Jun;4(2):92–98. doi: 10.1046/j.1369-6513.2001.00138.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Raffle A. E. New tests in cervical screening. Lancet. 1998 Jan 24;351(9098):297–297. doi: 10.1016/S0140-6736(05)78229-5. [DOI] [PubMed] [Google Scholar]
  15. Richardson A. Screening and the number needed to treat. J Med Screen. 2001;8(3):125–127. doi: 10.1136/jms.8.3.125. [DOI] [PubMed] [Google Scholar]
  16. Schoen Robert E., Weissfeld Joel L., Trauth Jeanette M., Ling Bruce S., Hayran Mutlu. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am J Gastroenterol. 2002 Feb;97(2):446–451. doi: 10.1111/j.1572-0241.2002.05484.x. [DOI] [PubMed] [Google Scholar]
  17. Schulz K. F., Chalmers I., Hayes R. J., Altman D. G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995 Feb 1;273(5):408–412. doi: 10.1001/jama.273.5.408. [DOI] [PubMed] [Google Scholar]
  18. Torgerson D. J., Donaldson C. An economic view of high compliance as a screening objective. BMJ. 1994 Jan 8;308(6921):117–119. doi: 10.1136/bmj.308.6921.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wald N. J. Guidance on terminology. J Med Screen. 2001;8(1):56–56. doi: 10.1136/jms.8.1.56. [DOI] [PubMed] [Google Scholar]
  20. Walter S. D., Day N. E. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983 Dec;118(6):865–886. doi: 10.1093/oxfordjournals.aje.a113705. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES